期刊文献+

抗HER-2嵌合抗体chA21对SKBR3细胞的增殖抑制及凋亡诱导作用 被引量:5

Effects of anti-HER-2 chimeric antibody chA21 on proliferation and apoptosis of SKBR3 cells
下载PDF
导出
摘要 目的探讨抗HER-2嵌合抗体chA21在体外抑制高表达HER-2的人乳腺癌SKBR3细胞增殖并诱导其凋亡的作用。方法采用MTT比色法、HE染色、透射电镜、流式细胞术(FCM)、原位末端标记技术(TUNEL)等方法观察和检测chA21对人乳腺癌SKBR3细胞增殖的抑制和凋亡的诱导。结果chA21(0.2~5.4mg.L^(-1))可抑制SKBR3细胞的增殖并诱导其凋亡,其作用呈剂量和时间依赖性。结论chA21在体外可抑制SKBR3细胞的增殖,诱导其凋亡是其主要作用途径之一。 Aim To explore the effects of anti-HER-2 chimeric antibody chA 21 on proliferation and apoptosis of SKBR3 cells.Methods MTT colorometric assay,HE staining,transmission electron microscopy,flow cytometry,and TUNEL were used to study the proliferation inhibition and apoptosis induction of SKBR3 cells by chA 21 in vitro.Results Proliferative inhibition rates and apoptotic index of SKBR3 cells were increased in a dose and time dependent manner after exposure to chA21(0.2~5.4 mg·L^-1).Conclusion chA 21 could remarkably inhibit proliferation of SKBR3 cells in vitro and apoptosis induction may be one of its main mechanisms.
出处 《中国药理学通报》 CAS CSCD 北大核心 2007年第11期1463-1466,共4页 Chinese Pharmacological Bulletin
基金 国家高技术研究发展计划(863计划)资助项目(No2004AA215260) 安徽省自然科学基金资助课题(No03043701) 安徽省教育厅自然科学基金资助课题(No2003kj185) 安徽医科大学青年科研基金资助项目(No2003ZR15)
关键词 HER-2 嵌合抗体 CHA21 乳腺癌 SKBR3 增殖 凋亡 HER-2 chimeric antibody chA 21 breast cancer SKBR3 proliferation apoptosis
  • 相关文献

参考文献3

二级参考文献33

  • 1马占好,张春艳,刘旭,李殿俊,赵强,张万峰,王日芝,韩丽珍.黄芪多糖对小鼠体内六种细胞系瘤株抑瘤作用的实验研究[J].中医药学报,1996,24(4):55-56. 被引量:54
  • 2Chothia C, Lesk A M, Tramontano A, et al. Conformations of immunologlobulin hypervariable domains[J]. Nature, 1989, 342:877-883.
  • 3Chothia C, Lesk A M, et al. Standard conformations for the canonical structures of immunoglobulins[J]. J. Mol. Biol., 1997, 273(4) :927-948.
  • 4Altschul S F, Gish W, Miller W, et al. Basic local alignment search tool[J]. J. Mol. Biol., 1990, 215:403-410.
  • 5Chothia C, Lesk A M. Canonical structures for the hypervariable regions of immunoglobulins[J]. J. Mol. Biol., 1987, 196:901-917.
  • 6Tramontano A, Chothia C, Lesk A M. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins[J]. J.Mol. Biol., 1990, 215:175-182.
  • 7Chothia C, Lesk A M, Gherardi E, et al. Structural repertoire of the human VH segments[J]. J. Mol. Biol., 1992, 227:799-817.
  • 8Chothia C, Novotny J, Bruccoleri R, et al. Domain association in immunoglobulin molecules the packing of variable domains[J]. J. Mol. Biol., 1985, 186:651-663.
  • 9Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops [J]. J.Mol. Biol., 1992, 224:487-499.
  • 10Guex N, Peitsch M C. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modelling[J]. Electrophoresis, 1997, 18:2714-2723.

共引文献97

同被引文献42

  • 1刘伦华,楼丽广.PTEN功能调节的研究进展[J].中国药理学通报,2005,21(7):778-781. 被引量:16
  • 2陈媛媛,李永进,毕利军.基于表面等离子共振的新型生物传感技术及其在生命科学中的应用[J].生物物理学报,2006,22(2):82-88. 被引量:11
  • 3Burstein H J.The distinctive nature of HER2-positive breast cancers[J].N Engl J Med,2005,353(16):1652-4.
  • 4Nahta R,Yu D,Hung M C,et al.Mechanisms of disease:understanding resistance to HER2-targeted therapy in human breast cancer[J].Nat Clin Pract Oncol,2006,3(5):269-80.
  • 5Cho H S,Mason K,Ramyar K X,et al.Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab[J].Nature,2003,421(6924):756-60.
  • 6Nagy P,Friedlander E,Tanner M,et al.Decreased accessibility and lack of activation of ErbB2 in JIMT-1,a herceptin-resistant,MUC4-expressing breast cancer cell line[J].Cancer Res,2005,65(2):473-82.
  • 7Kobayashi S,Boggon T J,Dayaram T,et al.EGFR mutation and resistance of non-small-cell lung cancer to gefitinib[J].N Engl J Med,2005,352(8):786-92.
  • 8Stephens P,Hunter C,Bignell G,et al.Lung cancer:intragenic ERBB2 kinase mutations in tumours[J].Nature,2004,431(7008):525-6.
  • 9Lee J W,Soung Y H,Seo S H,et al.Somatic mutations of ERBB2 kinase domain in gastric,colorectal,and breast carcinomas[J].Clin Cancer Res,2006,12(1):57-61.
  • 10Longva K E,Pedersen N M,Haslekas C,et al.Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2[J].Int J Cancer,2005,116(3):359-67.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部